MEDIPOST, announces a domestic and international clinical experience at the ISCT annual meeting2019/05/30STEM CELL THERAPEUTIC
MEDIPOST Clears Product Approval Renewal of CARTISTEM by the Ministry of Food and Drug Safety(MFDS)2019/03/26STEM CELL THERAPEUTIC
MEDIPOST, signs a contract with SK Bioland for an ankle joint indication2019/01/02STEM CELL THERAPEUTIC
Significant increase in the revenue of MEDIPOST stem cell therapeutics CARTISTEM in comparison to the previous year2018/04/20STEM CELL THERAPEUTIC
MEDIPOST Obtains Patent for its ‘CARTISTEM’ Production Technology’ in Six European Countries2017/12/06STEM CELL THERAPEUTIC
Chinese Securities Company Praises MEDIPOST as a “Company with Most Profitable Stem Cell Drug”2017/04/26STEM CELL THERAPEUTIC